Stericycle, Inc. (NASDAQ:SRCL) Q3 2022 Results Conference Call November 3, 2022 9:00 AM ET
Company Participants
Andrew Ellis - Vice President of Investor Relations and Enterprise Finance
Cindy Miller - Chief Executive Officer
Jan Zelenka - Chief Financial Officer and Chief Information Officer
Conference Call Participants
Sean Dodge - RBC Capital Markets
David Manthey - Baird
Scott Schneeberger - Oppenheimer
Michael Hoffman - Stifel
Operator
Hello all, and a warm welcome to the Third Quarter 2022 Stericycle's Earnings Conference Call. My name is Luisa and I'll be your operator today [Operator Instructions].
I now have the pleasure of handing over the call to Andrew Ellis, Vice President of Investor Relations and Enterprise Finance. Andrew, please go ahead.
Andrew Ellis
Good morning, and thank you for joining Stericycle's 2022 Third Quarter Earnings Call. On the call today will be Cindy Miller, our Chief Executive Officer; and Jan Zelenka, our Chief Financial Officer and Chief Information Officer. The discussion today includes forward-looking statements that involve risks and uncertainties. When we use words such as believes, expects, anticipates, estimates, may, plan, will, goal or similar expressions, we are making forward-looking statements. Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of our management about future events and are, therefore, subject to risks and uncertainties. Our actual results could differ significantly from those described in such forward-looking statements. Factors that could cause our actual results to differ are discussed in the safe harbor statement in our earnings press release and in greater detail within the risk factors in our filings with the U.S. Securities and Exchange Commission.
Our past financial performance should not be considered a reliable indicator of our future performance, and investors should not use historical results to anticipate future results or trends. We disclaim any obligation to update or revise any forward-looking statement other than in accordance with legal and regulatory obligations. On the call, we will discuss non-GAAP financial measures. For additional information and reconciliation to the most comparable U.S. GAAP measures, please refer to the schedules in our earnings press release, which can be found on Stericycle's Investor Relations website at investors.stericycle.com. The prepared comments for today's call correspond to an earnings presentation, which is also available at Stericycle's Investor Relations website. Throughout the call, we may reference specific slides from the presentation. This call is being recorded, and a replay will be available approximately 1 hour after the end of the conference call today until December 1, 2022. To access a replay of the call, dial (866)813-9403 in the U.S., (226)828-7578 in Canada or (44)-204-525-0658 if outside the U.S., Canada and enter a replay access code 984608. A replay of the webcast will also be available on the Stericycle Investor Relations website. Time-sense information provided during today's call, which is occurring on November 3, 2022 may no longer be accurate at the time of a replay. Any redistribution, retransmission or rebroadcast of this call in any form without the expressed written consent of Stericycle is prohibited.